Incidence of stroke symptoms among adults with chronic kidney disease: Results from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study

Nephrology Dialysis Transplantation

Volumn 27, Issue 1, 2012, Pages 166-173

  Muntner, Paul ^a,b   Judd, Suzanne E ^a   McClellan, William ^c   Meschia, James F ^d   Warnock, David G ^b   Howard, Virginia J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c EMORY UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

Author keywords

albuminuria; chronic kidney disease; stroke; stroke symptoms

Indexed keywords

ADULT; AGED; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; COMMUNICATION DISORDER; COMPREHENSION DISORDER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ESTIMATED GLOMERULUS FILTRATION RATE; FEMALE; GEOGRAPHIC DISTRIBUTION; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; LEARNING DISORDER; MALE; PARESTHESIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; STROKE; SUDDEN LOSS OF HALF VISION; SUDDEN LOSS OF VISION; SYMPTOM; VISUAL IMPAIRMENT; WEAKNESS;

ADULT; AGED; ALABAMA; ALBUMINURIA; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; KIDNEY FAILURE, CHRONIC; MALE; RISK FACTORS; STROKE;

EID: 84856685329     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr218     Document Type: Article

References (27)

1. Weiner DE, Tighiouart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315 (Pubitemid 38526012)
2. McCullough PA, Li S, Jurkovitz CT et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008; 51: S38-S45 (Pubitemid 351444716)
3. Abramson JL, Jurkovitz CT, Vaccarino V et al. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int 2003; 64: 610-615 (Pubitemid 36871933)
4. Ninomiya T, Perkovic V, Verdon C et al. Proteinuria and stroke: a meta-analysis of cohort studies. Am J Kidney Dis 2009; 53: 417-425
5. Chambless LE, Toole JF, Nieto FJ et al. Association between symptoms reported in a population questionnaire and future ischemic stroke: the ARIC study. Neuroepidemiology 2004; 23: 33-37 (Pubitemid 38142270)
6. Hart CL, Hole DJ, Smith GD. The relation between questions indicating transient ischaemic attack and stroke in 20 years of follow up in men and women in the Renfrew/Paisley Study. J Epidemiol Community Health 2001; 55: 653-656 (Pubitemid 32786367)
7. Howard VJ, McClure LA, Meschia JF et al. High prevalence of stroke symptoms among persons without a diagnosis of stroke or transient ischemic attack in a general population: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Arch Intern Med 2006; 166: 1952-1958 (Pubitemid 44540186)
8. Howard VJ, Lackland DT, Lichtman JH et al. Care seeking after stroke symptoms. Ann Neurol 2008; 63: 466-472 (Pubitemid 351614712)
9. Howard VJ, Cushman M, Pulley L et al. The reasons for geographic and racial differences in stroke study: objectives and design. Neuro-epidemiology 2005; 25: 135-143 (Pubitemid 41207066)
10. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
11. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
12. Levey AS, Cattran D, Friedman A et al. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 2009; 54: 205-226
13. Meschia JF, Brott TG, Chukwudelunzu FE et al. Verifying the stroke-free phenotype by structured telephone interview. Stroke 2000; 31: 1076-1080 (Pubitemid 30253528)
14. Jones WJ, Williams LS, Meschia JF. Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination. Stroke 2001; 32: 2232-2236 (Pubitemid 32954786)
15. Meschia JF, Lojacono MA, Miller MJ et al. Reliability of the questionnaire for verifying stroke-free status. Cerebrovasc Dis 2004; 17: 218-223 (Pubitemid 38529201)
16. Allison P. Estimating Parametric Regression Models with PROC LIFEREG. Survival Analysis Using SAS: A Practical Guide. SAS Publishing, Cary, NC: 2008; 61-110
17. Finkelstein DM. A proportional hazards model for interval-censored failure time data. Biometrics 1986; 42: 845-854 (Pubitemid 17134903)
18. Muntner P, He J, Hamm L et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13: 745-753 (Pubitemid 34183941)
19. Howard G, Safford MM, Meschia JF et al. Stroke symptoms in individuals reporting no prior stroke or transient ischemic attack are associated with a decrease in indices of mental and physical functioning. Stroke 2007; 38: 2446-2452 (Pubitemid 47329620)
20. Kannel WB, Cupples LA, Gagnon DR. Incidence, precursors and prognosis of unrecognized myocardial infarction. Adv Cardiol 1990; 37: 202-214 (Pubitemid 20298081)
21. Sheifer SE, Manolio TA, Gersh BJ. Unrecognized myocardial infarction. Ann Intern Med 2001; 135: 801-811 (Pubitemid 33051264)
22. Vermeer SE, Hollander M, van Dijk EJ et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003; 34: 1126-1129 (Pubitemid 36547501)
23. Leary MC, Saver JL. Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis 2003; 16: 280-285 (Pubitemid 36928621)
24. Khella S, Bleicher MB. Stroke and its prevention in chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 1343-1351
25. Muntner P, Hamm LL, Kusek JW et al. The prevalence of nontradi-tional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004; 140: 9-17
26. Weiner DE, Tighiouart H, Elsayed EF et al. The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis 2008; 51: 212-223
27. Parikh NI, Hwang SJ, Larson MG et al. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 2006; 166: 1884-1891 (Pubitemid 44455172)